Search Result "AML, acute T cell leukemias"
Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)
Journal: Current Drug Targets
Volume: 18 Issue: 3 Year: 2017 Page: 304-314
Author(s): Joshua F. Zeidner,Matthew C. Foster
Immunotherapy of Acute Myeloid Leukemia
Journal: Current Pharmaceutical Biotechnology
Volume: 2 Issue: 3 Year: 2001 Page: 209-215
Author(s): Arthur E. Frankel, Maria R. Baer, Donna E. Hogge, Robert K. Stuart
Novel and Emerging Drugs for Acute Myeloid Leukemia
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 5 Year: 2012 Page: 522-530
Author(s): E. M. Stein,M. S. Tallman
Targeting the Acute Myeloid Leukemia Stem Cells
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 2 Year: 2010 Page: 104-110
Author(s): Alexandre Krause, Luciana M. Fontanari Krause, Eduardo M. Rego
Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 473-489
Author(s): Vaibhav Agrawal,Olumide B. Gbolahan,Maximilian Stahl,Amer M. Zeidan,Mohammad Abu Zaid,Sherif S. Farag,Heiko Konig
Understanding Unmet Needs in the Older Acute Myeloid Leukemia (AML) Patient
Journal: Current Cancer Therapy Reviews
Volume: 12 Issue: 4 Year: 2016 Page: 246-252
Author(s): Pablo Loarte,Irina Dashkova,Leanne Tortez,Anna Dashkova,Andrzej Kozikowski,Ramy Ibrahim,Renee Pekmezaris
Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 28 Year: 2020 Page: 4673-4698
Author(s): Parham Jabbarzadeh Kaboli,Lingling Zhang,Shixin Xiang,Jing Shen,Mingxing Li,Yueshui Zhao,Xu Wu,Qijie Zhao,Hanyu Zhang,Ling Lin,Jianhua Yin,Yuanlin Wu,Lin Wan,Tao Yi,Xiang Li,Chi Hin Cho,Jing Li,Zhangang Xiao,Qinglian Wen
Oncogenic Signaling in Acute Myeloid Leukemia
Journal: Current Drug Targets
Volume: 8 Issue: 2 Year: 2007 Page: 237-246
Author(s): Christian H. Brandts, Wolfgang E. Berdel, Hubert Serve
Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia
Journal: Current Drug Targets
Volume: 18 Issue: 3 Year: 2017 Page: 315-331
Author(s): Hanna A. Knaus,Christopher G. Kanakry,Leo Luznik,Ivana Gojo
Dysregulated YAP1/Hippo Pathway Contributes to Doxorubicin (ADM)Resistance in Acute Myeloid Leukemia (AML)
Journal: Current Pharmaceutical Biotechnology
Volume: 24 Issue: 5 Year: 2023 Page: 676-685
Author(s):